Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs
- Peter Sandercock
- , Eivind Berge
- , Martin Dennis
- , John Forbes
- , Peter Hand
- , Joseph Kwan
- , Steff Lewis
- , Richard Lindley
- , Aileen Neilson
- , Joanna Wardlaw
- University of Edinburgh
- Western General Hospital
- University of Oslo
- Royal Melbourne Hospital
- University Hospital Southampton NHS Foundation Trust
- HealthEcon Ltd
Research output: Contribution to journal › Review article › peer-review